In line with these findings, Baer et al. identified a mutational pattern including SRSF2, U2AF1, SF3B1, ASXL1, EZH2, BCOR, and STAG2 that allowed to distinguish AML-MRC from non-AML-MRC patients. This evidence concerns the gene STAG2 and acute myeloid leukemia.